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Abstract
We implemented an ECG data-warehousing project to promote cross-fertilization of scientific
knowledge, resources and ideas that will advance the understanding of quantitative ECG and
cardiac safety. While other open ECG databases are available, our Telemetric and Holter ECG
Warehouse (THEW) proposes unique sets of continuous digital ECGs recorded in cardiac
patients, healthy individuals and individuals exposed  to non-cardiac and cardiac drugs. In
this paper, we present briefly the content and the current research triggered by this initiative.
(Cardiol J 2010; 17, 4: 416–419)
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Introduction
The need for accurate and fast exchange of in-
formation has been the rationale for the development
of computer technologies and the driving force for
the continuous automation of our surroundings. In
the medical arena, digital conversion has happened
at every level, from the patient/care providers’ in-
teraction to the electronic data capture systems in
large clinical trials. Digital tools have streamlined the
information flow from patients to scientists through
physicians (and other health care providers). Yet, the
information acquired in clinical studies and other
medical investigations is rarely shared with the
broader scientific community, even years after the
study findings have been released. Legal protection
of patient information, and technological challenges,
were the main barriers to better public access to
medical data.
In 1995, the European Parliament and the Council
of the European Union (E.U.) adopted a “Directive on
the Protection of Individuals with Regard to the
Processing of Personal Data and on the Free
Movement of Such Data”. The following year, the U.S.
Congress enacted the Health Insurance Portability
and Accountability Act (HIPAA) in order to improve
the efficiency and effectiveness of the nation’s
healthcare system by encouraging the widespread use
of electronic data interchange. Today, clinical studies
must ensure the protection of private health
information through data de-identification i.e. deletion
of information that would allow a patient to be
identified from any electronic dataset: 18 fields were
defined as identifiable data, including name, date of
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birth, social security number and contact information
(a complete list can be found in the Appendix 1).
Consequently, the legal and technological barriers no
longer exist, and developing an open database depends
primarily on logistic and financial resources. The sto-
ring and sharing of medical data are associated with
costs for infrastructure development, maintenance,
and technical support to users. For an organization to
bear such costs while ensuring an altruistic scientific
mission is a challenge.
In this paper, we describe how our group has
designed the Telemetric and Holter ECG Ware-
house (THEW) initiative to facilitate the sharing of
a large database of medical information, including
primarily continuous ECG data. Legal, technical and
financial solutions were designed and successfully
implemented, triggering collaborative projects with
both federally-funded organizations and private
companies. We describe the content of the THEW,
as well as the research activities which have been
initiated based on its data.
Mission statement
The objective of the THEW is to provide ac-
cess to ECG data for the design and validation of
analytic methods to advance the field of quantita-
tive ECG, with a strong focus on cardiac safety.
Data available in the THEW (Table 1)
The THEW databases encompass ECG record-
ings from cardiac patients and healthy subjects. The
group of cardiac patients consists of individuals with
acute myocardial infarction, coronary artery disease,
or patients with atrial fibrillation. Patients with con-
genital or acquired forms of long QT syndrome are
hosted as well. The group of healthy individuals en-
compasses ECGs from ‘normal’ individuals, where
normal is defined as the absence of cardiac history,
no blood pressure, no chronic illness and normal
physical examination.
Clinical files describing patients’ clinical infor-
mation are associated with each database of ECG
files. The content of each clinical information file is
described in detail on the website of the initiative
(www.thew-project.org).
Technical specifications
of the ECG signals
The hosted ECG recordings are continuous, with
a length varying from ten minutes to 24 hours, and
with a sampling frequency of 180 Hz, 200 Hz and 1000
Hz. According to the database, the ECG recordings
have different amplitude resolutions (coded on 10,
12 or 16 bits) and different numbers of leads (3- or
12-lead recordings). Three-lead signals are recorded
using a pseudo-orthogonal configuration (X, Y, and Z).
Twelve leads follow the Holter configuration, in which
limb leads are reported to the torso (treadmill con-
figuration or Mason-Likar lead placement) and the
precordial leads follow the standard resting 12-lead
ECG configuration. See Table 1 for details about the
technical specifications of the ECG recordings in each
THEW database.
Accessing data from the THEW
All databases from the THEW are available
worldwide via the internet. Because the THEW is
supported by the NHLBI, not-for-profit organiza-
tions can freely access the databases. However, we
require these organizations to provide a single-page
form describing their scientific objectives to the
THEW Data Use Committee (DUC), whose role is
Table 1. Databases available in the THEW.
Study Leads ECGs Sampling Rec. Pts. Size
Healthy 3 24-h 200 201 201 22 GB
Coronary artery disease 3 24-h 200 271 271 29 GB
Acute myocardial infarction 3 24-h 200 160 93 18 GB
Thorough QT study 3 24-h 200 175 34 6 GB
TdPs 12 24-h 180 6 6 2 GB
History of TdPs 12 4 min 1,000 84 37 242 MB
Atrial fibrillation 12 15–20 min 1,000 73 73 1.7 GB
Thorough QT study 12 24-h 1,000 140 70 190 GB
Genotyped congenital LQTS 2–3 24-h 200 480 307 14 GB
TdPs — torsades de pointes; LQTS — long QT syndrome; Leads — number of leads; ECGs — average duration of the electro-
cardiograms; Sampling — sampling frequency expressed in Hz; Rec. — number of recordings; Pts. — number of patients;
Size — size of the dataset excluding the clinical information
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to provide feedback about potential collaborators
(as an option) and scientific counseling to the
submitter(s). Also, the THEW DUC receives users’
feedback so as to improve data content, data struc-
ture or organizational processes. For-profit orga-
nizations do not have to send such a form, but they
are instead required to pay a membership fee to
access data from the repository.
Two options are offered to access the THEW
data. First, the THEW client application is a soft-
ware developed in collaboration with Global Instru-
mentations (Syracuse, NY, USA) providing: 1) easy
secured access to ECG and clinical data; 2) an ECG
viewer tool; 3) an ECG tool for interval (epochs)
extraction from Holter recordings; 4) a system de-
velopment kit based on a simple application pro-
gram interface (API); and 5) a tool to download ECG
signal and beat annotation. The second option,  the
secured file transfer protocol (SFTP), allows the
downloading of ECG files in a well-documented for-
mat (the so-called  ISHNE format) for both the raw
ECG signal and the cardiac beat annotations [1].
Data from the THEW can be used for research,
development and educational activities. No restric-
tion exists related to publications, inventions and
patents i.e. intellectual property based on the THEW
data is fully owned by the inventor and cannot be
claimed by either the THEW or the organization(s)
that provided the data to the THEW. Importantly,
data from the THEW cannot be shared between
organizations without prior consent from the THEW
steering committee (regardless of their status). Such
a requirement is necessary in order to have for-profit
companies help us continue to develop our activities
through membership data-access fees.
Current research
During this past year, 11 organizations have
joined our initiative to conduct research and deve-
lop ECG-related technologies. While private com-
panies have focused on the validation of current
technologies, such as the automation of QT inter-
val measurements for drug safety trials [2], the
work from academic centers is related to new tech-
nologies including ECG markers of drug-induced
torsades de pointes [3, 4], QT/RR modeling [5], and
ECG filtering [6]. With an increasing number of
groups joining our initiative, we have spawned many
more activities encompassing other arenas of quan-
titative electrocardiography, they include repola-
rization dynamics, atrial fibrillation detection, and
phenotype-genotype correlation in patients with the
congenital long QT syndrome.
The THEW and other
ECG-related initiatives
Helping the scientific community by develo-
ping an ECG repository is not a novel concept.
There are several examples of ECG databases built
over recent decades. The MIT initiative around
Physionet, the AHA-BIH Arrhythmia Database, and
the CSE database are examples of ECG databases
that have greatly benefited scientists worldwide.
The Physiobank [7] is probably one of the most suc-
cessful ECG databases available today (see
Appendix 1). We believe our initiative will comple-
ment the Physiobank ECG database for several
reasons: 1) the CES will contain unique sets of
ECGs and clinical data from regulatory clinical trials
(not available in the Physiobank); and 2) our
initiative will facilitate the analysis of large sets of
long-term digital Holter recordings (we host prima-
rily 24-hour recordings). The ECG data contribu-
tion of the THEW is expected to grow quickly. Over
the past two years, our initiative has received ECG
recordings from for-profit organizations and
academic centers encompassing 1,600 recordings
from 1,092 individuals, representing close to 283 GB
of continuous digital ECGs.
Conclusions
The sharing of scientific data reinforces open
scientific inquiry. It encourages diversity of analy-
sis and opinion while promoting new research and
facilitating the education of future generations of
scientists. We have started an initiative to develop
a unique repository of medical information and con-
tinuous ECG signals. After less than two years of
activities, 15 publications have been released based
on data from our repository, focusing primarily on
designing improved or novel technologies for the
quantitative analysis of ECG. A stream of orga-
nizations has already joined our initiative, and we
invite more organizations and individuals to join
our endeavor by using data from the repository,
sharing their data and/or initiating collaborative
projects.
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Appendix 1. List of the fields to be removed from
medical datasets so as to be HIPAA compliant
1. Name
2. Postal address (geographic subdivisions smal-
ler than state)
3. All elements of dates, except year (birth date,
if over 89, must be aggregated)
4. Phone number
5. Fax number
6. E-mail address
7. Social Security number
8. Medical Record number
9. Health Plan number
10. Bank account number
11. Certificate/license numbers
12. URL
13. IP address
14. Vehicle identifier
15. Device ID
16. Biometric ID
17. Full face/identifying photo
18. Any other unique identifying number, charac-
teristic or code
